about
Identification of sequences common to more than one therapeutic target to treat complex diseases: simulating the high variance in sequence interactivity evolved to modulate robust phenotypesNew perspectives in glioblastoma antiangiogenic therapyFibroblast growth factor receptor signaling as therapeutic targets in gastric cancerIndividualized treatment of gastric cancer: Impact of molecular biology and pathohistological featuresAnti-angiogenic therapies for metastatic colorectal cancer: current and future perspectivesFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersTargeted therapy in advanced bladder cancer: what have we learned?FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical SignaturesPrognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.The role of tumor microenvironment in therapeutic resistanceExploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migrationEvidence-Based Theory for Integrated Genome Regulation of Ontogeny--An Unprecedented Role of Nuclear FGFR1 SignalingBayesian methods for expression-based integration of various types of genomics data.Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancerSystems analysis of oxidant stress in the vasculatureGreat challenges in molecular medicine: toward personalized medicine.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesThe Fibroblast Growth Factor signaling pathwayFunctional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.The antitumor potential of Interleukin-27 in prostate cancer.Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma.Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma.Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer.Pedican: an online gene resource for pediatric cancers with literature evidenceArray CGH Analysis of Paired Blood and Tumor Samples from Patients with Sporadic Wilms TumorUpregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.Selecting causal genes from genome-wide association studies via functionally coherent subnetworks.Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancerSelective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.Novel Bioluminescent Binding Assays for Ligand-Receptor Interaction Studies of the Fibroblast Growth Factor FamilyFerulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.Identifying therapeutic targets in gastric cancer: the current status and future directionCombined CSL and p53 downregulation promotes cancer-associated fibroblast activationFunctional Conservation of the Glide/Gcm Regulatory Network Controlling Glia, Hemocyte, and Tendon Cell Differentiation in DrosophilaNuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.
P2860
Q21146715-08EAE6D1-75E8-4AD3-B9E5-B306A2FBB505Q26746028-DC78CE07-AFBA-468F-9D84-1119F39FDDA2Q26764932-62E88CE4-6A23-4EFE-88C8-F7F822B87B76Q26776198-7869B488-BBB0-4F06-9582-466DE5B0F872Q26826817-E34D6CB2-AC3A-45D2-A155-53CDE112EDC9Q26998955-473E2A28-FD56-4142-AADB-E9706037EF70Q27009469-3DEB3C73-D62E-4EAC-B2CE-ED805EF54B3AQ27684227-F4528D47-5CF5-4966-BE02-680034F7FFB0Q27853061-468B42EA-4E5B-475A-BD60-DF2C88018C38Q28069049-8781FC97-B28E-442F-98C6-86A2449B128FQ28077512-8DAABCEC-949A-4141-ACC2-45864C14940CQ28078898-CC558F0B-288C-40FF-B096-1194E6828F0CQ30668548-5EA3531B-A6E4-444F-8E01-10E55CFFCA85Q33648854-15BEBF5E-7CCE-4FD2-8BAE-B4165EA07C4AQ33733751-A382964E-715C-4FAB-8DD1-0440D83B29A1Q34306963-B12D85CE-BCD0-47A9-815B-4B4D45FD625EQ34391221-91AD683A-16DC-486F-A4C9-D288AEB32FF9Q34391443-41D60FB3-2E16-4ACB-84EE-6B8E21C5EF1EQ34467171-580BA5B8-1DBF-45B8-B9BC-E748C67D729DQ34469971-59F431A8-EB9A-4275-8B3A-45AADA4A5FBAQ34504939-36D298A0-86DE-41DC-90BE-E082BC27B920Q34525925-B7E20613-AF21-493D-A724-00A75C628576Q34786440-A3DC6BE6-63CB-4A86-A8BF-BDBBCD731E1FQ35070321-8075BF1C-AD54-4EC1-982A-0DE9905DDB0CQ35179821-F4671355-EDD7-460B-8563-9944A6D5C3D5Q35273337-9A5053D2-C804-498E-BCB6-2B2E10D06A41Q35740537-3646C1AD-9318-49EC-A100-AFE74E3ED0FEQ35759070-74A731DE-14FF-4290-81B9-7A583D734123Q35781460-A2053321-CFBE-43E2-8825-CF2C1D0AFA0CQ35781914-B200B5F7-6775-440D-A5CC-50BB2E1605FCQ35808066-3ECCE44D-4B5C-432B-9DBC-2FCC469EB2B7Q35870855-575B1B02-E51F-484C-AB75-79A84E953195Q35930608-9314258C-39F0-4A4B-978F-0EA9C982623DQ36077282-50B8194E-C9EF-409F-BCE2-8A4553C9F7EAQ36247353-0341D647-389A-448F-AC4B-BCBB5EC7DEEFQ36260612-97804E1F-9798-40C9-87B6-FA92064407EFQ36398732-CF31C664-FB76-4E04-8FDB-014DD9E1E1CFQ36425130-9EEF5C2B-A9CF-4393-A5B2-7DBB283D8D5AQ36429793-002B7E69-0ED1-4B07-9247-5B4671FCBEAFQ36464545-3FF430EF-F12E-46B9-830A-F648FA41443E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
FGF receptors: cancer biology and therapeutics
@ast
FGF receptors: cancer biology and therapeutics
@en
FGF receptors: cancer biology and therapeutics
@nl
type
label
FGF receptors: cancer biology and therapeutics
@ast
FGF receptors: cancer biology and therapeutics
@en
FGF receptors: cancer biology and therapeutics
@nl
prefLabel
FGF receptors: cancer biology and therapeutics
@ast
FGF receptors: cancer biology and therapeutics
@en
FGF receptors: cancer biology and therapeutics
@nl
P2860
P3181
P356
P1476
FGF receptors: cancer biology and therapeutics
@en
P2093
Hitoshi Nakagama
Masaru Katoh
P2860
P304
P3181
P356
10.1002/MED.21288
P407
P577
2014-03-01T00:00:00Z